CoreCap Advisors, LLC
- SEC CIK
- 0001902501
- Latest filing
- Jul 6, 2026
SPRO holding history
Spero Therapeutics, Inc. in every 13F filed by CoreCap Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SPRO overviewAll 13F holders of SPROFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −50−100.0% | Sold out | Holders |
| Q1 2025 | 50 | $36 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 50 | $52 | <0.1% | −142−74.0% | Reduced | Holders |
| Q3 2024 | 192 | $257 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 192 | $250 | <0.1% | +50+35.2% | Added | Holders |
| Q1 2024 | 142 | $244 | <0.1% | +142 | New | Holders |
| Q1 2023 | – | – | – | – | Not filed | Holders |
| Q4 2022 | 142 | $246 | <0.1% | +142 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −142−100.0% | Sold out | Holders |
| Q2 2022 | 142 | $0 | 0.0% | +142 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −142−100.0% | Sold out | Holders |
| Q4 2021 | 142 | $2.00K | <0.1% | – | No prior filing | Holders |